Company: CDT
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022373
Chunk: 36

Company: CDT Equity Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 8
Chunk 36
---
, the Company sold 704,270
and 888,388
shares of the Company’s Common Stock through the Sales Agreement, respectively. For the nine months ended September 30, 2025,
the Company received proceeds of $18.0
million, net of commissions payable to A.G.P. of $0.6
million. As of the date of this Quarterly Report on Form 10-Q, the Company has utilized the remaining $1.8
million available under the Sales Agreement (see Note 16).

    21

Share
Repurchase Program

On
April 10, 2025, the Company’s Board of Directors authorized a share repurchase program under which the Company may purchase up
to $1.0
million of its outstanding Common Stock. Under the program, CDT may repurchase shares from time to time through open market
transactions or other methods in compliance with SEC Rule 10b-18. Purchases will be executed by The Benchmark Company, the
Company’s appointed broker, and will be subject to market conditions, corporate liquidity requirements, regulatory
considerations, and other factors. As of September 30, 2025, the Company has repurchased an aggregate of 1,464
shares of its outstanding Common Stock at an average price of $70.80 per
share and paid approximately $2,000
in commission to the broker. The repurchased shares were recorded as treasury stock within the condensed consolidated balance
sheets. During the third quarter, the Company cancelled all of the previously repurchased shares and removed the share activity
from treasury stock on the condensed consolidated statements of changes in shareholders’ deficit. As of September 30, 2025, no balance
remains within treasury stock on the condensed consolidated balance sheets and the cancelled shares are no longer included within the
issued and outstanding Common Stock balance.

11.
Net Loss Per Share Attributable to Common Stockholders

Potentially
dilutive securities (upon conversion) that were not included in the diluted per share calculations because they would have been anti-dilutive
were as follows:

Schedule
of Potentially Dilutive Securities 

    As of
                                                                  September 30,  
    As of
                                                                  September 30, 

    2025  
    2024 
  
    Public Warrants 
     1,164  
     1,164 
  
    PIPE Warrants 
     -  
     166 
  
    A.G